On his most recent assessment, the CLL was in a minimal residual disease positive complete remission with 0.25 × 109 CLL-cells/L whilst there was a continued CML MMR with a BCR-ABL:ABL ratio of 0.029%. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.